AVENIO Tumor Tissue Surveillance Kit – Longitudinal Tumor Burden Monitoring

Material Number: N/A

Next-generation sequencing (NGS) assay designed to establish a baseline for tumor burden monitoring in lung and colorectal cancer, as well as to assess for minimal residual disease (MRD) and contains 471 frequently mutated regions associated with the presence of disease across 197 genes.

Description

Roche AVENIO Tumor Tissue Surveillance Kit is used for longitudinal tumor burden monitoring.